A NEW ORAL HYPOGLYCEMIC AGENT, REPAGLINIDE MINIMIZES RISK OF HYPOGLYCEMIA IN WELL-CONTROLLED NIDDM PATIENTS

Citation
B. Tronier et al., A NEW ORAL HYPOGLYCEMIC AGENT, REPAGLINIDE MINIMIZES RISK OF HYPOGLYCEMIA IN WELL-CONTROLLED NIDDM PATIENTS, Diabetologia, 38, 1995, pp. 195-195
Citations number
NO
Categorie Soggetti
Endocrynology & Metabolism","Medicine, General & Internal
Journal title
ISSN journal
0012186X
Volume
38
Year of publication
1995
Supplement
1
Pages
195 - 195
Database
ISI
SICI code
0012-186X(1995)38:<195:ANOHAR>2.0.ZU;2-P